VERTEX PHARMACEUTIC (NASDAQ:VRTX)
37.90
-0 (-0%)
| VERTEX PHARMACEUTIC (NASDAQ:VRTX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $37.90 | 52 Week High | $44.24 | ||
| Open | $37.74 | 52 Week Low | $25.94 | ||
| Day High | $38.36 | P/E | N/A | ||
| Day Low | $37.33 | EPS | $-3.84 | ||
| Volume | 1,208,365 | ||||
| More VRTX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| AMLN | 4 | HGSI | 4 |
| BCRX | 3 | GSK | 3 |
| EHSI | 3 | MRX | 3 |
| QGEN | 3 | GILD | 3 |
| CIT | 2 | ACOR | 2 |
| YRCW | 2 | AFFY | 2 |
Entities who have mentioned VRTX
- JPMorgan | View Related Stories »
- Banc of America | View Related Stories »
- Piper Jaffray | View Related Stories »
- Citi | View Related Stories »
- Merriman Curhan Ford | View Related Stories »
- Needham & Company | View Related Stories »
- Trading Radar | View Related Stories »
- Deutsche Bank | View Related Stories »
- 13G | View Related Stories »
- Robert W Baird | View Related Stories »
- Soleil Securities | View Related Stories »
- Argus | View Related Stories »
- Bankruptcy | View Related Stories »
- Morgan Stanley | View Related Stories »
- Merrill Lynch | View Related Stories »
- Factory Orders | View Related Stories »
- UBS | View Related Stories »
- Calyon Securities | View Related Stories »
- Oscar Gruss | View Related Stories »
- Pali Research | View Related Stories »
- Morgan Keegan & Company | View Related Stories »
- Goldman Sachs | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- Charles Gasparino | View Related Stories »
- Piper Jaffray Alpha List | View Related Stories »
View All Major News StreetInsider.com Major News for VRTX
- Vertex Pharma (VRTX) Reports Better-Than-Expected Q4 Loss of $0.66
- Vertex Pharma (VRTX) Reports Better-Than-Expected Q3 Loss of $0.71; Reiterates FY09 Outlook
- Vertex Pharma (VRTX) Reports In-Line Q1 Loss of $0.82
View All ReportsStreetInsider.com Reports on VRTX
- Piper Jaffray Names Inspire (ISPH) and Vertex Pharmaceuticals (VRTX) as Top Picks
- Vertex Pharma (VRTX) Reports Better-Than-Expected Q4 Loss of $0.66
- Trading Radar for 02/04: Bunge (BG), Spectra Energy (SE), MasterCard (MA), Con-Way (CNW), Hospira (HSP) Report
- Vertex Pharma (VRTX) Announces Positive VX-809 Phase 2a
- Oppenheimer Upgrades Vertex Pharma (VRTX) to Outperform
View All Press ReleasesCompany Press Releases on VRTX
- Vertex Pharmaceuticals Reports 2009 Financial Results and Highlights Recent Progress in Hepatitis C and Cystic Fibrosis Development Programs
- Vertex Announces Results from Phase 2a Trial of VX-809 Targeting the Defective Protein Responsible for Cystic Fibrosis
- Vertex Pharmaceuticals Announces the Date of its Full Year 2009 Financial Results Conference Call and Webcast
- Emerging Healthcare Achieves Due Diligence Milestone With ThromboVision
- Emerging Healthcare Solutions Sees Aggressive Business Model Expansion
StreetInsider Reports on VRTX by Category
View All BlogsBlogs on VRTX
- Wall Street Breakfast: Must-Know News
- 2010: A Big Year for Big Pharma
- Innovative Drug Companies Headline the Gainers
- Monday Options Update: XLF, ETFC, CF, HGSI, EEM, BEBE, SMH and VRTX
- Monday Options Recap
View All FilingsSEC Filings on VRTX
- Form SC 13G VERTEX PHARMACEUTICALS Filed by: Capital World Investors
- Form 4 VERTEX PHARMACEUTICALS For: Feb 04 Filed by: Sachdev Amit
- Form 4 VERTEX PHARMACEUTICALS For: Feb 04 Filed by: Silva Paul M
- Form 4 VERTEX PHARMACEUTICALS For: Feb 04 Filed by: Emmens Matthew
- Form 4 VERTEX PHARMACEUTICALS For: Feb 04 Filed by: BOGER KENNETH S
Comments on recent VRTX articles
Comments on VRTX
No comments are currently available.
on Aug 15, 2008
at 11:06 AM Cure of hepatitis Is there a way to place an low amount of an antibacterial formula w/ isopropyl alcohol which would bring fungus/ mold/ bacteria out of the system.
Article: Vertex Pharma (VRTX) Higher On Analyst Upgrade